Utah Medical Products, Inc.
UTMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$222.25M
Close$
$90.68
35.1% upside
Current Fair Value
35.1% upsideUndervalued by 35.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $222.25 Million |
|---|---|
| Enterprise Value | $134.91 Million |
| Dividend Yield | $1.24 (1.77%) |
| Earnings per Share | $3.41 |
| Beta | 0.36 |
| Outstanding Shares | 3,185,000 |
Return
| Return on Equity | 8.59% |
|---|---|
| Return on Assets | 8.42% |
| Return on Invested Capital | 9.50% |
Valuation & Multiples
| P/E Ratio | 21.15 |
|---|---|
| PEG | -178.09 |
| Price to Sales | 6.1 |
| Price to Book Ratio | 1.77 |
| Enterprise Value to Revenue | 3.74 |
| Enterprise Value to EBIT | 11.59 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 23, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 22, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.89%▼ 67.58% |
|---|---|
| Total Invested | $1.96M▼ 98.60% |
| Investors Holding | 11▼ 108.00% |
ESG Score
No data
About Utah Medical Products, Inc.
CEO: Kevin Cornwell Utah Medical Products, Inc. with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hund...